title: The Lipid Portion of Activated Platelet-Rich Plasma Significantly Contributes to Its Wound Healing Properties.
abstract: Objective:Platelet-rich plasma (PRP) is a popular choice for the treatment of chronic wounds. Current dogma attributes these healing properties to the peptide growth factors of PRP. However, PRP is also rich in bioactive lipids whose contribution to healing has not been characterized and warrants investigation due to the protease-rich environment of chronic wounds.Approach:The lipid fraction of PRP was tested with respect to proliferation and migration of primary adult human dermal fibroblasts (HDFa)±exposure to chronic wound fluid (CWF). This fraction was also characterized via LC-MS/MS for bioactive lipids. A synthetic formulation of the bioactive lipid composition was developed and tested for the ability to overcome proliferative growth arrest induced by CWF.Results:The data demonstrate the ability of the lipid fraction of PRP to significantly enhance the migration and proliferation of HDFa, and to overcome the proliferative growth arrest induced by CWF. Furthermore, the synthetic lipid formulation generated following characterization of the PRP lipidome demonstrated a similar ability to overcome proliferative arrest of HDFa in the presence of CWF.Innovation:For the first time, we demonstrate the relevance of the lipid fraction of PRP toward the biology of wound healing. These studies open the possibility of altering the lipid profile of PRP via diet or exogenous pathway manipulation to obtain a better healing outcome.Conclusion:The lipid fraction of PRP is under investigated and yet relevant component in wound healing. The current study demonstrates the relevance of this fraction in wound healing by PRP.
authors.affiliation: Hunter Holmes McGuire Veterans Administration Medical Center , Richmond, Virginia. ; Department of Biochemistry and Molecular Biology, Virginia Commonwealth University , Richmond, Virginia.
authors.forename: Lauren Alexis
authors.initials: LA
authors.lastname: Hoeferlin
authors.affiliation: Department of Biochemistry and Molecular Biology, Virginia Commonwealth University , Richmond, Virginia.
authors.forename: Quoc K
authors.initials: QK
authors.lastname: Huynh
authors.affiliation: Department of Biochemistry and Molecular Biology, Virginia Commonwealth University , Richmond, Virginia.
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Mietla
authors.affiliation: Hunter Holmes McGuire Veterans Administration Medical Center , Richmond, Virginia. ; Department of Biomedical Engineering, Parks College of Engineering and Technology, Saint Louis University , St Louis, Missouri.
authors.forename: Scott A
authors.initials: SA
authors.lastname: Sell
authors.affiliation: Hunter Holmes McGuire Veterans Administration Medical Center , Richmond, Virginia.
authors.forename: Jason
authors.initials: J
authors.lastname: Tucker
authors.affiliation: Hunter Holmes McGuire Veterans Administration Medical Center , Richmond, Virginia. ; Department of Biochemistry and Molecular Biology, Virginia Commonwealth University , Richmond, Virginia. ; The Massey Cancer Center , Richmond, Virginia. ; Victoria Johnson Center for Critical Care Research, Virginia Commonwealth University, Richmond, Virginia.
authors.forename: Charles Edward
authors.initials: CE
authors.lastname: Chalfant
authors.affiliation: Hunter Holmes McGuire Veterans Administration Medical Center , Richmond, Virginia. ; Department of Surgery, Virginia Commonwealth University , Richmond, Virginia. ; Victoria Johnson Center for Critical Care Research, Virginia Commonwealth University, Richmond, Virginia.
authors.forename: Dayanjan Shanaka
authors.initials: DS
authors.lastname: Wijesinghe